Cisplatin, ara-C and etoposide (PAE) in the treatment of recurrent childhood brain tumors
Data up to Jan 2025
Total Citations Per Year
Abstract
References (20)
Nonparametric Estimation from Incomplete Observations
1992 • 45,923 citations
Nonparametric Estimation from Incomplete Observations
1958 • 37,219 citations
Peripheral sensory neuropathy and cisplatin chemotherapy
1984 • 368 citations
The wolf in the cello
1973 • 209 citations
Experimental chemotherapy of human medulloblastoma cell lines and transplantable xenografts with bifunctional alkylating agents.
1988 • 134 citations
Brain tumor chemotherapy: an evaluation of agents in current use for phase II and III trials.
1980 • 122 citations
Cisplatin in recurrent pediatric brain tumors A pog phase II study a pediatric oncology group study
1985 • 117 citations
Synergistic lethal effect of cis-dichlorodiammineplatinum and 1-beta-D-arabinofuranosylcytosine.
1981 • 115 citations
Cisplatin in the treatment of recurrent childhood primary brain tumors.
1988 • 112 citations
Preirradiation cisplatin and etoposide in the treatment of high-risk medulloblastoma and other malignant embryonal tumors of the central nervous system: a phase II study.
1990 • 105 citations
Cisplatin therapy in recurrent childhood brain tumors.
1982 • 100 citations
A clinical trial of the oral form of 4′-demethyl-epipodophyllotoxin-β-D ethylidene glucoside (NSC 141540) VP 16–213
1975 • 97 citations
Etoposide (VP-16-213) in malignant brain tumors: a phase II study.
1984 • 92 citations
A phase II study of cisplatin therapy in recurrent childhood brain tumors
1989 • 92 citations
Interaction of etoposide and cisplatin in an in vitro tumor model.
1987 • 83 citations
Enhanced cis-platinum neurotoxicity in pediatric patients with brain tumors
1983 • 55 citations
Cisplatin plus cytosine arabinoside in adults with malignant gliomas
1984 • 31 citations
Intensive chemotherapy including cisplatin with or without etoposide for children with soft‐tissue sarcomas
1987 • 25 citations
Peripheral neuropathy after high-dose cytosine arabinoside, daunorubicin, and asparaginase consolidation for acute nonlymphocytic leukemia.
1986 • 23 citations
Evaluation of cisplatin in children with recurrent brain tumors.
1985 • 19 citations